Marcus Deans argues that marketing should be at the heart of market access strategy.
(Feb 25, 2010)Marcus Deans explores the competitive advantages of value-based pricing
(Mar 23, 2010)Marcus Deans examines why market access depends on understanding the needs of payers.
(Mar 23, 2010)Marcus Deans explains the necessity of knowing why and how payers make decisions.
(Apr 20, 2010)Marcus Deans explains why the continued relevance of reps depends on developing new skill sets to maintain a competitive edge.
(May 24, 2010)The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs